Life Sciences
What Happened at AGBT? Experts Scrutinize the Meeting’s Announcements
On this episode of GEN Live, we’ll give you a full AGBT breakdown. Experts from both the spatial and NGS fields will join the show to consider the announcements…
Originally Aired: Wednesday, February 15, 2023
Time: 9:00 am PT, 12:00 pm ET, 18:00 CET
Going to the AGBT (Advances in Genome Biology and Technology) conference this year? Whether attending the meeting in Florida this year or not, a full debrief on the latest news in NGS or spatial technologies is critical to understanding where those fields are today. Historically, the AGBT meeting has been the time for NGS companies to make big announcements. However, in the past few years, spatial biology has joined the mix.
On this episode of GEN Live, we’ll give you a full AGBT breakdown. Experts from both the spatial and NGS fields will join the show to consider the announcements made this year. We’ll cover everything from the research presented and the technologies introduced to the promises made by companies. And we’ll explain what it means for the next year in spatial and NGS— two fields where the next 12 months could change the field and make or break some of the current players.
GEN moderator:
• Julianna LeMieux, PhD – Deputy Editor-in-Chief, GEN
Sponsored by
The post What Happened at AGBT? Experts Scrutinize the Meeting’s Announcements appeared first on GEN – Genetic Engineering and Biotechnology News.
bioinformatics genomics medicalWittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….